Moderna's COVID-19 vaccine candidate moves into late-stage trial
11:42, 27/07/2020, Monday
REUTERS

File photo
Moderna Inc said on Monday it has started a U.S. government-backed late-stage trial evaluating its COVID-19 vaccine candidate, mRNA-1273, in about 30,000 adults who do not have the respiratory illness caused by the new coronavirus.
The main goal of the study will be prevention of the symptomatic COVID-19 disease, the company said.
Reklam yükleniyor...
Reklam yükleniyor...
Comments you share on our site are a valuable resource for other users. Please be respectful of different opinions and other users. Avoid using rude, aggressive, derogatory, or discriminatory language.